ClinicalTrials.Veeva

Menu

Sequential Use of Foley's Catheter and Misoprostol Versus Misoprostol Alone for Induction of Labour: a Multicentre Randomised Controlled Trial

K

Kazakhstan's Medical University "KSPH"

Status and phase

Completed
Phase 4

Conditions

Induction of Labor

Treatments

Drug: Misoprostol 200mcg Tab

Study type

Interventional

Funder types

Other

Identifiers

NCT06249815
IRB-23-2024

Details and patient eligibility

About

Evaluation of efficacy of inducing labour using a Foley's catheter and low dose oral misoprostol sequentially, in comparison with low dose oral misoprostol alone.

Full description

a multicentre, open-label randomised controlled trial in 2 hospitals in the Almaty,Kazakhstan. Women with a term singleton pregnancy in cephalic presentation, an unfavourable cervix, intact membranes, and without a previous caesarean section will be randomly allocated to 2 groups: 1 group -cervical ripening with Foley's catheter for 16 hour and sequentially 25 μg oral misoprostol once every 2 hour, 2 nd group- 25 μg oral misoprostol once every 2 hour. The primary outcome will be vaginal delivery within 24 hours(to evaluate effectiveness) and secondary outcoms 1-5-min Apgar score and hospitalization in ICU, rate of hyperstimulation ,hemorrage,chorioamnionitis (for evaluating safety)

Enrollment

400 patients

Sex

Female

Ages

18 to 49 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • women with an unfavourable cervix who will scheduled for induction of labour

Exclusion criteria

  • Women with previous caesarean sections unable to give informed consent Multiple pregnancy History of allergy to misoprostol Ruptured membranes All cases when physiological childbirth is impossible (placenta previa,transverse position of the fetus )

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

400 participants in 2 patient groups

Foley catheter + misoprostol
Active Comparator group
Description:
-cervical ripening with transcervical Foley catheter 22 F for 16 hours, then sequentially 25 μg oral misoprostol once every 2 hour.Max 200 μg
misoprostol
Active Comparator group
Description:
25 μg oral misoprostol alone once every 2 hour, Max 200 μg.
Treatment:
Drug: Misoprostol 200mcg Tab
Drug: Misoprostol 200mcg Tab

Trial contacts and locations

2

Loading...

Central trial contact

DILFUZA SULTANMURATOVA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems